Stay updated on Nivolumab and RT in Localized Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThis page update includes a new revision tag (v3.4.2) and removal of older revision notices (v3.4.1) and a government-funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA government funding notice was added stating NIH Clinical Center is open and updates can be found at opm.gov, and the page version was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedThe page now includes a glossary toggle and updates several page-labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision tag to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe changes consist of revision metadata (Revision: v3.3.4 and the previous v3.3.3) and do not modify any study content, eligibility criteria, or results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a consolidated Locations section listing Michigan and New York as study sites and removed the separate Michigan Locations and New York Locations sections. The footer now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.3%

Stay in the know with updates to Nivolumab and RT in Localized Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.